Leap Therapeutics, Inc.
(NASDAQ : LPTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
2.32%289.181.4%$863.03m
CELGCelgene Corp.
-1.02%108.201.3%$561.40m
AMGNAmgen, Inc.
1.00%222.881.3%$532.69m
GILDGilead Sciences, Inc.
0.93%64.891.0%$395.88m
VRTXVertex Pharmaceuticals, Inc.
2.11%214.421.9%$329.41m
ILMNIllumina, Inc.
1.26%310.523.5%$328.11m
REGNRegeneron Pharmaceuticals, Inc.
0.75%342.752.6%$272.61m
EXASEXACT Sciences Corp.
3.48%85.0224.0%$225.98m
ALXNAlexion Pharmaceuticals, Inc.
2.20%110.342.0%$183.35m
SGENSeattle Genetics, Inc.
0.82%116.686.1%$142.03m
BMRNBioMarin Pharmaceutical, Inc.
1.58%76.364.3%$128.89m
SRPTSarepta Therapeutics, Inc.
0.15%98.0514.6%$118.74m
AAgilent Technologies, Inc.
1.49%79.101.6%$99.52m
BGNEBeiGene Ltd.
2.45%200.822.1%$92.59m
NBIXNeurocrine Biosciences, Inc.
-0.62%113.935.0%$87.59m

Company Profile

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.